Marvellon Pharmaceuticals Private Limited, a active private limited company, was established on 04 April 2019 in Panchkula, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100HR2019PTC079580. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
Formerly known as Vvpb Pharmaceuticals Private Limited. Its leadership includes Anil Kumar (Director), Amit Kumar (Director). Past directors included Gopalakrishnam Venkatasubramanyam, Vikas Punia, Amit Dhankar. It holds ₹1.70 Cr open charges and ₹8.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Near Punjab National Bank Vill - Marranwala, P.O - Nanakpur, Tehsi, L - Kalka, Panchkula, Haryana, 134102.
U24100HR2019PTC079580
079580
04 April 2019
₹3.00 M
₹3.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Marvellon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar | Director | 27 Oct 2020 | Current |
| Amit Kumar | Director | 27 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 02 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 27 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 27 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 17 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 10 Dec 2022 | Past |
| Pramod Abcsdd | Additional Director | 10 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Marvellon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.89% increase. The company also saw a substantial improvement in profitability, with a 59.3% increase in profit. The company's net worth Soared by an impressive increase of 30.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Marvellon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹16,960,000.00
₹8,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 2022 | Canara Bank | ₹1.70 Cr | Open |
| 13 Dec 2019 | Others | ₹8.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Marvellon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Marvellon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marvellon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Marvellon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Marvellon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on A charge with Canara Bank of Rs. 16.96 M registered on 13 Jul 2022 with Charge ID 100606477 was modified on 16 Aug 2023. was documented.
Progress on A charge with Canara Bank amounted to Rs. 16.96 M with Charge ID 100606477 was registered on 13 Jul 2022. was documented.
A charge registered on 13 Dec 2019 via Charge ID 100322087 with Others was fully satisfied on 16 Nov 2020. was recorded as a recent event.
The activity Anil Kumar was appointed as a Director was appointed as a Director on 27 Oct 2020 & has been associated with this company since 5 years 1 month . was completed.
The CIN of Marvellon Pharmaceuticals Private Limited is U24100HR2019PTC079580.
Marvellon Pharmaceuticals Private Limited is headquartered at Near Punjab National Bank Vill - Marranwala, P.O - Nanakpur, Tehsi, L - Kalka, Panchkula, Haryana, 134102.
Marvellon Pharmaceuticals Private Limited was incorporated on 04 April 2019.
The current directors of Marvellon Pharmaceuticals Private Limited are
The primary industry of Marvellon Pharmaceuticals Private Limited is Manufacturing.
Marvellon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Marvellon Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX